(Q79858864)
Statements
Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions (English)
Luke PP
Deng JP
Lian D
O'Connell PJ
Garcia B
Jevnikar AM